Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8

Abu Bakar, Ruzilawati (2008) Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8. ["eprint_fieldopt_thesis_type_phd" not defined] thesis, USM.

[img]
Preview
PDF
Download (1MB) | Preview

Abstract

Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4 and CYP2C8 enzymes.

Item Type: Thesis (["eprint_fieldopt_thesis_type_phd" not defined])
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Kampus Kesihatan (Health Campus) > Pusat Pengajian Sains Perubatan (School of Medical Sciences) > Thesis
Depositing User: Mr Firdaus Mohamad
Date Deposited: 11 Feb 2016 07:56
Last Modified: 15 May 2017 04:43
URI: http://eprints.usm.my/id/eprint/29661

Actions (login required)

View Item View Item
Share